A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo

Clinical trial NCT03642340 · UNKNOWN

Trial details

NCT number: NCT03642340
Sponsor: IlDong Pharmaceutical Co Ltd
Status: UNKNOWN
Study type: OBSERVATIONAL

Chronic Hepatitis b

Start date: 2017-05-15
Primary completion: 2023-05-14
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.